Integra Lifesciences Holdings (IART) Current Leases (2019 - 2026)

Integra Lifesciences Holdings (IART) has 8 years of Current Leases data on file, last reported at $13.9 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases fell 1.69% year-over-year to $13.9 million; the trailing twelve-month figure through Mar 2026 stood at $13.9 million (down 1.69% YoY), and the FY2025 full-year result was $14.0 million, down 3.58% from the prior year.
• Current Leases eased to $13.9 million in Q1 2026, from $14.0 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $16.3 million in Q1 2024 to a low of $12.7 million in Q2 2022.
• A 5-year average of $14.4 million and a median of $14.5 million in 2023 frame the typical range for Current Leases.
• Across the five-year window, Current Leases climbed 14.71% in 2023 and decreased 13.08% in 2025, its largest moves.
• Tracing IART's Current Leases over 5 years: stood at $14.6 million in 2022, then rose by 4.51% to $15.3 million in 2023, then declined by 4.87% to $14.5 million in 2024, then fell by 3.58% to $14.0 million in 2025, then dropped by 0.62% to $13.9 million in 2026.
• Business Quant data shows IART's Current Leases at $13.9 million in Q1 2026, $14.0 million in Q4 2025, and $13.8 million in Q3 2025.